Company / Capital Expenditures
Biohaven Ltd. Capital Expenditures History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$4.0M
FY2024
5-year range
$938.0K / $6.1M
FY2020-FY2024
Trend
+32.8%
vs FY2023
Sector context
#80 of 194
Health Care
What the data says
At $4M, Biohaven Ltd.'s capital expenditures ranks #80 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 5 years, ranging from $938,000 in FY2021 to $6M in FY2022.
Based on SEC 10-K filings.
$4M in FY2024 with a 3-year CAGR of +62.8%.
Declined from $6M to $4M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +62.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#80 of 194 in Health CareTop 41% of 194This company $4.0M Sector average $117.5M
▼
-96.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +62.8%, indicating consistent growth.
- In FY2024, capital expenditures increased 32.8% year-over-year.
- Ranks #80 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.0M | +32.8% |
| FY2023 | $3.0M | -49.8% |
| FY2022 | $6.1M | +547.5% |
| FY2021 | $938.0K | -14.5% |
| FY2020 | $1.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026